|Articles|April 12, 2011
Pfizer to Sell Capsugel
Capsugel will be sold for $2.375 billion in cash.
Advertisement
Pfizer announced plans to sell Capsugel (Peapack, NJ), the world’s leading provider of pharmaceutical and dietary supplement capsules, to private equity firm Kohlberg Kravis Roberts & Co. Capsugel will be sold for $2.375 billion in cash.
Last year, Capsugel generated approximately $750 million in revenue and manufactured more than 180 billion hard capsules. The transaction is expected to be completed this year. Capsugel will maintain its corporate presence in the United States and its global headquarters in New Jersey.
Newsletter
From ingredient science to consumer trends, get the intel you need to stay competitive in the nutrition space—subscribe now to Nutritional Outlook.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
Artemis International: 30 Years of Science-Backed Berry and Botanical Innovation
2
Certifications, Clinical Trials, and Consumer Trust: How SGS NutriSource Serves the Industry
3
Pycnogenol supplementation effective for lipedema symptom reduction, new clinical trial demonstrates
4
New LOAM prebiotic fiber formula includes NutriLeads’ Benicaros ingredient
5
